thalassaemia — Thalassaemia patients account for 34 per cent of all blood transfusions in Cyprus, as highlighted by Health Minister Michael Damianos during a press conference on Friday. This statistic underscores the critical need for a robust blood donation system as the nation gears up to implement a national blood strategy.
Photo: cyprus-mail.com
- “Emergency health situations, including pandemics, have also negatively influenced donor availability,” Damianos added, drawing attention to the multifaceted nature of the issue.
Damianos articulated the pressing challenges Cyprus faces in ensuring a steady supply of blood and blood products, challenges that mirror those in many other European nations. He explained that the decline in the number of eligible blood donors, compounded by socio-economic factors such as young people relocating overseas for education and a low birth rate, has further strained the blood supply.
“Emergency health situations, including pandemics, have also negatively influenced donor availability,” Damianos added, drawing attention to the multifaceted nature of the issue.
The Blood Centre in Cyprus is charged with managing blood donations, adhering to EU standards and guidelines set forth by the World Health Organisation. This organisation plays a pivotal role in maintaining the quality and safety of blood products.
“Transfusions of blood and its derivatives are not just standard medical procedures; they are essential therapeutic interventions that cater to a wide array of clinical conditions,” the minister remarked, emphasising the importance of maintaining a reliable blood supply.
In collaboration with the national blood donation council, the government has been drafting a comprehensive national blood strategy. This plan includes a guidebook for the proper use of blood, which is grounded in documented international practices, ensuring that Cyprus remains at the forefront of blood donation standards.
Furthermore, Damianos introduced a new EU regulation concerning substances of human origin, which Cyprus must fully implement by August 7, 2027. This regulation aims to enhance the safety and quality standards applicable to blood and its components, fostering greater solidarity within the healthcare framework.
“Our goal is not only to maintain but also to improve Cyprus’ standing in Europe regarding blood collection. We aim to uphold our exceptionally low residual risk of transmitting infectious agents, and to promote self-sufficiency through voluntary, unpaid donations,” he concluded.
